Evopoint and Kaken also ring in the new year with multiple deals. Biocytogen licenses antibodies against a specified target derived from its RenMice platform technology to Hansoh Pharma.

A review of the Phoenix '97 CEO conference shows there's a long way to go in bridging the communication gap between large and small companies.

Back from the brink of financial disaster, distributors are getting healthy with a strategy that draws limits around what they can do for customers and suppliers.

Focusing on franchises not individual products, BMS is developing strategies for its Zimmer and ConvaTec divisions that enable them to grow at once independently and synergistically. BMS is exploring potential links between its various businesses which capitalize on new market or technology opportunities without sacrificing the skills that made each company successful.